Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i vs Tempus ECG-Low EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Canon Medical Systems Corporation
VS
by Tempus

AI Verdict

Tool A is a CT scanner with integrated AI for enhancing image quality and reducing dose across various medical imaging applications, including cardiology. Tool B is a software-only AI tool that analyzes ECGs specifically to detect signs of low left ventricular ejection fraction, aiding in heart failure risk identification. While both leverage AI in cardiology, Tool A focuses on advanced imaging acquisition, whereas Tool B provides a diagnostic interpretation of existing ECG data.

Choose Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i if…

Choose the Aquilion Prime SP if your facility requires a high-performance CT imaging system capable of delivering superior image quality and dose optimization across a broad range of clinical applications, including advanced cardiology, oncology, and emergency medicine. This system is ideal for detailed anatomical visualization, precise diagnosis, and managing diverse patient populations, from pediatric to bariatric, with features like AiCE-i for deep learning reconstruction and SEMAR for metal artifact reduction.

View Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i →

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if you need an efficient, AI-powered software solution to screen patients aged 40 or older for signs associated with low left ventricular ejection fraction (LVEF ≤40%) using standard 12-lead ECG recordings. This tool is best suited for integrating into existing clinical workflows in cardiology, emergency medicine, or internal medicine to quickly identify at-risk individuals who may require further diagnostic evaluation for heart failure.

View Tempus ECG-Low EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i Tempus ECG-Low EF
Deployment On-premise (CT System) and mobile-capable configuration for multi-facility deployment. Integrates with current ECG platforms and electronic health records (EHRs).
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tempus ECG-Low EF

Tool B, as a software-only solution providing a binary output, likely offers a simpler and more intuitive user experience for clinicians receiving the results, integrating seamlessly into existing digital workflows. While Tool A emphasizes workflow optimization for CT technologists, the inherent complexity of operating a physical CT scanner makes Tool B's software interface generally more straightforward for the end-user clinician.

Clinical Value

Tempus ECG-Low EF

Tool B offers a highly specific and actionable clinical value by identifying patients at risk of low LVEF from routine ECGs, potentially leading to earlier diagnosis and intervention for a critical condition. While Tool A provides broad clinical value through superior image quality across multiple specialties, Tool B's direct diagnostic aid for a specific, high-impact condition gives it a slight edge in terms of immediate, targeted clinical actionability.

Pricing & Value

Tie

Both tools lack publicly available pricing information, making a direct comparison of their pricing and value impossible. As one is a major capital equipment purchase (Tool A) and the other is a software solution (Tool B), their cost structures and value propositions are inherently different and cannot be assessed without specific vendor quotes.

Enterprise Readiness

Tempus ECG-Low EF

Both tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and offering BAAs. Tool B, as a software solution designed for integration into existing healthcare facility workflows, likely offers greater flexibility and scalability for deployment across an enterprise compared to the physical installation and maintenance requirements of a CT scanner (Tool A).

Innovation

Tie

Both tools showcase significant innovation in their respective domains. Tool A's deep learning reconstruction (AiCE-i) represents a fundamental advancement in imaging technology, improving the core diagnostic capability of CT. Tool B's application of AI to ECGs for predictive risk assessment of low LVEF is also highly innovative, leveraging existing data for novel clinical insights.

Support & Docs

Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i

Canon Medical Systems, as an established medical device manufacturer, offers a more comprehensive and explicitly documented support and service infrastructure for its complex CT scanner, including dedicated service, interoperability, and product security information. While Tempus AI undoubtedly provides support for its software, the publicly available information does not detail the same breadth of explicit support and documentation offerings as Canon.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i Tempus ECG-Low EF
Name Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i Tempus ECG-Low EF
Company Canon Medical Systems Corporation Tempus AI
Primary Function CT scanner featuring Deep Learning Reconstruction (AiCE-i) for superior image quality, noise reduction, and dose optimization, with comprehensive clinical capabilities. AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure.
Core Technology Deep Learning Reconstruction (AiCE-i), 40-row CT System (expandable to 80), 160 slices per rotation. AI-powered algorithm for ECG analysis, trained on a large dataset of over 930,000 ECGs.
Target Patient Population/Condition Diverse patient needs (pediatric to bariatric), supporting advanced applications in cardiology, oncology, and emergency medicine. Patients 40 years or older at risk of heart failure, specifically detecting signs of low LVEF (u226440%).
Key Output/Result Superior image quality, noise reduction, and dose optimization for CT imaging. Binary output (Low LVEF Detected / Not Detected) to aid clinicians in further evaluation.

Videos

Demos, reviews, and walkthroughs featuring Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i and Tempus ECG-Low EF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Aquilion Prime SP (Tool A) is a CT scanner designed for comprehensive diagnostic imaging across various specialties, including cardiology, oncology, and emergency medicine, with a focus on superior image quality and dose optimization. Tempus ECG-Low EF (Tool B) is an AI software specifically developed to analyze 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in at-risk patients 40 years or older.
Tool A utilizes AiCE-i (Advanced intelligent Clear-IQ Engine - integrated) Deep Learning Reconstruction to improve image quality, reduce noise, and optimize dose during CT scans. Tool B employs an AI-powered algorithm to analyze 12-lead ECG recordings, identifying patterns that indicate a risk of low LVEF.
Tool A requires patient input for CT scanning and generates detailed diagnostic images. Tool B analyzes resting, non-ambulatory 12-lead ECG recordings and provides a binary output (Low LVEF Detected / Not Detected) for interpretation.
The Aquilion Prime SP (Tool A) includes SURECardio Helical Prospective for cardiac imaging and arrhythmia compensation as part of its broader diagnostic capabilities. Tempus ECG-Low EF (Tool B) is exclusively focused on cardiology, providing AI-powered analysis of ECGs to detect signs associated with low LVEF in patients 40 years or older at risk of heart failure.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.